The McLean Screening Instrument for Borderline Personality Disorder: A Review

Borderline personality disorder (BPD) poses significant challenges for early identification and diagnosis due to its intricate symptomatology that overlaps with other psychiatric illnesses. To address this challenge, the McLean Screening Instrument for BPD (MSI-BPD) was developed to identify individuals displaying potential BPD symptoms. This review aims to consolidate the current limited body of research on the MSI-BPD, delving into its origins, the rigor of its validation process, its practicality in clinical settings, and potential applications. By comprehensively examining these aspects, clinicians and researchers involved in BPD assessment and diagnosis can develop a deeper understanding of the instrument's utility. The MSI-BPD's development involved meticulous consideration of BPD diagnostic criteria, resulting in a tool tailored to effectively capture relevant symptoms. Validation studies have provided supportive evidence for its accuracy in identifying individuals at risk of BPD, thereby underlining its utility as a resource for early screening and intervention in clinical settings. However, it is essential to acknowledge that, while the MSI-BPD demonstrates satisfactory psychometric properties and utility as a screening tool for BPD, its diagnostic accuracy may vary across diverse populations. Consequently, clinicians and academics must judiciously consider sample characteristics and potential limitations when utilizing this instrument in both clinical and research contexts. Recognizing the advantages and potential applications of the MSI-BPD within a comprehensive approach to addressing BPD is important for professionals working in the field of BPD assessment and diagnosis. It is important to emphasize that the MSI-BPD is a screening tool and one data point in understanding patients presenting with complex symptomatology.